13 results on '"Serke M"'
Search Results
2. Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trial
3. 1308P Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS Q61 mutations
4. 1028P BIOLUMA: A phase II trial of nivolumab in combination with ipilimumab to evaluate efficacy and safety in lung cancer and to evaluate biomarkers predictive for response – results from the NSCLC cohort
5. 1508TiP - Durvalumab in frail and elder patients with stage four NSCLC: The DURATION trial
6. 1330P - Impact of next generation TKI and co-occurring mutations in ALK-positive NSCLC patients: Results of the Network Genomic Medicine
7. 1316P - Genetic Variability and Clinical Presentation of Patients with Non-Small Cell Lung Cancer (Nsclc) Harboring Met-Amplifications
8. 1314P - Occurrence and Characteristics of Keap1-Mutations in Patients with Non-Small Cell Lung Cancer (Nsclc)
9. 1308P - Ret Translocation in Adenocarcinoma of the Lung
10. 1238P - Try - a Phase Ii Study to Evaluate Safety and Efficacy of Combined Trastuzumab and the Hsp90 Inhibitor Auy922 in Advanced Non-Small-Cell Lung Cancer (Nsclc) with Her2 Overexpression or Amplification or Mutation
11. 1202P - Pemetrexed (Pem) and Cisplatin (Cis) with Concurrent Thoracic Radiation After Pem + Cis Induction in Patients (Pts) with Unresectable Locally Advanced (La) Nonsquamous Non-Small Cell Lung Cancer (Ns-Nsclc): Results in Different Age Groups (≤70 Yrs, >70 Yrs)
12. 9144 Cetuximab in combination with gemcitabine/docetaxel or carboplatin/gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: toxicity data from an ongoing Phase II/III trial (GemTax IV)
13. Weekly docetaxel as second line chemotherapy in advanced non small cell lung cancer (NSCLC): Final results and survival analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.